Vericel reports Q4 EPS 38c vs. 26c last year

Reports Q4 revenue $75.4M, consensus $76.47M. Q4 non-GAAP adjusted EBITDA increased 34% to $29.9M, representing adjusted EBITDA margin of 40%, an increase of approximately 530 basis points versus the prior year. “The company executed extremely well in 2024, delivering high revenue growth across both franchises and very strong margin expansion and profitability,” said CEO Nick Colangelo. “We are entering 2025 with a great deal of momentum and expect another year of high revenue growth and significant growth in profitability and cash generation driven by the strength in our core portfolio and increasing utilization of MACI Arthro.”